<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Ask Eddie: Your cancer AI Agent]]></title><description><![CDATA[We are focused on providing access, new technology, and optimal care for cancer patients and their loved ones.]]></description><link>https://www.askeddie.org/blog</link><generator>RSS for Node</generator><lastBuildDate>Thu, 17 Sep 2026 23:03:45 GMT</lastBuildDate><atom:link href="https://www.askeddie.org/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Lost in Translation: Why Understanding Your Diagnosis Can Be Half the Battle]]></title><description><![CDATA[Picture holding a pathology report full of words like "invasive," "poorly differentiated," and "lymphovascular invasion" — with no one to translate what any of it actually means for you. That gap between what's written and what's understood is called health literacy, and it may be one of the strongest predictors of how well someone survives cancer. Low health literacy isn't about intelligence. It's about systemic communication failures: rushed appointments, dense medical jargon, and...]]></description><link>https://www.askeddie.org/post/lost-in-translation-why-understanding-your-diagnosis-can-be-half-the-battle</link><guid isPermaLink="false">6aac467eea7c1d3d266c7a5e</guid><pubDate>Thu, 17 Sep 2026 20:00:01 GMT</pubDate><dc:creator>Nomad&apos;s Lens</dc:creator></item><item><title><![CDATA[Who Gets a Seat at the Table? The Diversity Problem in Cancer Clinical Trials]]></title><description><![CDATA[Every new cancer drug, every breakthrough therapy, every treatment protocol that saves lives tomorrow — it all starts in a clinical trial today. Which raises an uncomfortable question: if certain communities are consistently left out of those trials, are we building tomorrow's medicine for everyone, or just for some? Clinical trial disparities occur when certain populations face lower participation, limited access, or reduced eligibility for cancer research. The consequences aren't abstract —...]]></description><link>https://www.askeddie.org/post/who-gets-a-seat-at-the-table-the-diversity-problem-in-cancer-clinical-trials</link><guid isPermaLink="false">6aac3c834676eb915b41ba17</guid><pubDate>Thu, 17 Sep 2026 19:16:53 GMT</pubDate><dc:creator>Nomad&apos;s Lens</dc:creator></item><item><title><![CDATA[Beyond the Statistics: Cancer, Culture, and Trust in Indigenous Communities]]></title><description><![CDATA[Numbers rarely tell the whole story, and nowhere is that more true than in Indigenous cancer care. Indigenous peoples across First Nations, Inuit, and Métis communities often have lower cancer incidence than the general population — and yet face higher mortality. That contradiction is the story. It's not that Indigenous communities get more cancer. It's that when cancer arrives, it's too often caught late, treated in environments that don't feel safe, and unsupported by a healthcare system...]]></description><link>https://www.askeddie.org/post/beyond-the-statistics-cancer-culture-and-trust-in-indigenous-communities</link><guid isPermaLink="false">6aac3b89c277db7715a7bf4d</guid><pubDate>Thu, 17 Sep 2026 19:14:18 GMT</pubDate><dc:creator>Nomad&apos;s Lens</dc:creator></item><item><title><![CDATA[When Your Zip Code Becomes a Risk Factor: The Rural Cancer Divide]]></title><description><![CDATA[Imagine needing a colonoscopy, but the nearest gastroenterologist is two hours away, your job doesn't offer paid time off, and the weather might make the drive dangerous half the year. For millions of people in rural America, that's not a hypothetical — it's Tuesday. Rural communities face higher cancer mortality, lower screening rates, and dramatically reduced access to oncology specialists. It's not that rural patients get sicker cancers. It's that distance itself becomes a...]]></description><link>https://www.askeddie.org/post/when-your-zip-code-becomes-a-risk-factor-the-rural-cancer-divide</link><guid isPermaLink="false">6aac3ab3c277db7715a7bd54</guid><pubDate>Thu, 17 Sep 2026 19:11:02 GMT</pubDate><dc:creator>Nomad&apos;s Lens</dc:creator></item><item><title><![CDATA[The Cancer Gap No One Should Accept: Understanding Black Community Disparities]]></title><description><![CDATA[Here's a hard truth: two people can walk into the same hospital with the same cancer, and walk out with very different odds — not because of their biology, but because of everything that happened before they ever got sick. That's the story behind cancer disparities in Black communities. Black Americans face higher mortality rates for several major cancers — breast, prostate, colorectal, and lung — despite similar, and sometimes even lower, rates of getting the disease in the first place. Let...]]></description><link>https://www.askeddie.org/post/the-cancer-gap-no-one-should-accept-understanding-black-community-disparities</link><guid isPermaLink="false">6aac2fe7d351bc6bc51552da</guid><pubDate>Thu, 17 Sep 2026 18:48:47 GMT</pubDate><dc:creator>Derrick J Beech, MD, FACS</dc:creator></item></channel></rss>